Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-04T17:12:29.840Z Has data issue: false hasContentIssue false

Adverse Syndromes and Psychiatric Drugs: a Clinical Guide. Peter Haddad, Serdar Dursan & Bill Deakin. (eds) Oxford: Oxford University Press, 2004, £29.95 pb, 330 pp. ISBN: 0-19-852748-9

Published online by Cambridge University Press:  02 January 2018

Shubhra Mace*
Affiliation:
South London and Maudsley NHS Trust
Rights & Permissions [Opens in a new window]

Abstract

Type
The columns
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 2006. The Royal College of Psychiatrists

There are books to suit different purposes. For example, one may read a book for pleasure, use another for a particular reference and another still as an academic text. Then there is a book such as this one that fulfils all of these criteria.

This book covers a number of adverse syndromes associated with drugs used in psychiatry, including relatively common scenarios such as extrapyramidal side-effects and extending to less well-understood phenomena such as diabetes mellitus and neuroleptic malignant syndrome. All the chapters follow the same format including sections on clinical features of the syndrome, differential diagnosis, management, risk factors and prevention, with a summary at the end.

There are few surprises in the recommendations, which on the whole appear to be in line with current practice guidelines, although less so with practice. One of the great strengths of the book is that it can be used as a guide to aid clinical practice rather than solely as an academic text.

This book is a welcome addition to a slowly growing collection of practical guides on drugs used in psychiatry. It is a stimulating read and will appeal to academics and clinicians alike. I recommend it to psychiatrists, pharmacists, general practitioners, nurses and any other healthcare professionals involved with or interested in drug treatment in psychiatry.

References

Peter Haddad, Serdar Dursan & Bill Deakin (eds) Oxford: Oxford University Press, 2004, £29.95 pb, 330 pp. ISBN: 0-19-852748-9

Submit a response

eLetters

No eLetters have been published for this article.